At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk.

BACKGROUND The clinical high-risk state for psychosis (HRP) is associated with an enhanced probability of developing a psychotic episode over a relatively short period of time. However, the extent to which different diagnostic types of illness develop remains unclear. METHODS A systematic review was performed to identify studies of HRP participants reporting International Classfication of Diseases/Diagnostic and Statistical Manual of Mental Disorders diagnostic outcomes at follow-up. Demographic, clinical, and methodological variables were extracted from each publication or obtained directly from its authors. A meta-analysis was performed of transition to schizophrenic (SP) or affective psychoses (AP) and to specific diagnostic categories. Statistical heterogeneity and small study bias were assessed, and meta-regressions were performed. RESULTS Twenty-three studies were retrieved, including a total of 2182 HRP participants, 560 (26%) of them developed a frank psychotic disorder over the follow-up time (mean = 2.35 y). Among HRP participants who developed psychosis, 73% were diagnosed with SP and only 11% with AP (Risk Ratio, RR = 5.43, 95% CI from 3.35 to 8.83). The specific transition risk to ICD/DSM schizophrenia was of 15.7% (over 2.35y). Heterogeneity was statistically significant and moderate in magnitude. Use of basic symptoms criteria in the baseline clinical assessment was associated with a further increase in the proportion progressing to SP vs AP (RR = 17.1). There was no evidence of publication bias and the sensitivity analysis confirmed robustness of the above results. CONCLUSIONS The HRP state is heterogeneous in term of longitudinal diagnoses; however, the current HRP diagnostic criteria appear strongly biased toward an identification of early phases of SP rather than AP.

[1]  P. Mcguire,et al.  Neuroimaging predictors of transition to psychosis—A systematic review and meta-analysis , 2010, Neuroscience & Biobehavioral Reviews.

[2]  T. Lencz,et al.  Generalized and Specific Neurocognitive Deficits in Prodromal Schizophrenia , 2006, Biological Psychiatry.

[3]  K. Kendler,et al.  The Roscommon Family Study. IV. Affective illness, anxiety disorders, and alcoholism in relatives. , 1993, Archives of general psychiatry.

[4]  D. Umbricht,et al.  High remission rates from an initial ultra-high risk state for psychosis , 2010, Schizophrenia Research.

[5]  A. Altamura,et al.  Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder , 2008, Neuropsychiatric Disease and Treatment.

[6]  Fred W. Sabb,et al.  Language network dysfunction as a predictor of outcome in youth at clinical high risk for psychosis , 2010, Schizophrenia Research.

[7]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[8]  P. Fusar-Poli,et al.  Integrating the negative psychotic symptoms in the high risk criteria for the prediction of psychosis. , 2007, Medical hypotheses.

[9]  A. Yung,et al.  Can Clinicians Predict Psychosis in an Ultra High Risk Group? , 2010, The Australian and New Zealand journal of psychiatry.

[10]  Mark W. Lipsey,et al.  Practical Meta-Analysis , 2000 .

[11]  E. Fonseca-Pedrero,et al.  Symptomatic and functional outcome in youth at ultra-high risk for psychosis: A longitudinal study , 2009, Schizophrenia Research.

[12]  H. Engeland,et al.  Transition and remission in adolescents at ultra-high risk for psychosis , 2011, Schizophrenia Research.

[13]  J. Klosterkötter,et al.  Predicting first-episode psychosis by basic symptom criteria. , 2007 .

[14]  P. Fusar-Poli,et al.  Should attenuated psychosis syndrome be included in DSM-5? , 2012, The Lancet.

[15]  I. Hickie,et al.  Intervention in individuals at ultra-high risk for psychosis: a review and future directions. , 2009, The Journal of clinical psychiatry.

[16]  Jeffrey A. Lieberman,et al.  International clinical practice guidelines for early psychosis , 2005, British Journal of Psychiatry.

[17]  C. Correll,et al.  Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome. , 2007, Schizophrenia bulletin.

[18]  A. Bechdolf,et al.  Experience of trauma and conversion to psychosis in an ultra‐high‐risk (prodromal) group , 2010, Acta psychiatrica Scandinavica.

[19]  H. Haker,et al.  Sub-clinical psychosis symptoms in young adults are risk factors for subsequent common mental disorders , 2011, Schizophrenia Research.

[20]  Paolo Fusar-Poli,et al.  Neurofunctional correlates of vulnerability to psychosis: A systematic review and meta-analysis , 2007, Neuroscience & Biobehavioral Reviews.

[21]  A. Riecher-Rössler,et al.  The ABC schizophrenia study: a preliminary overview of the results , 1998, Social Psychiatry and Psychiatric Epidemiology.

[22]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[23]  S. Strakowski,et al.  Preventative Strategies for Early-Onset Bipolar Disorder , 2010, CNS drugs.

[24]  M. Kempton,et al.  Predicting Psychosis: Meta-analysis of Transition Outcomes in Individuals at High Clinical Risk , 2013 .

[25]  A. Yung,et al.  Should a risk syndrome for first episode psychosis be included in the DSM-5? , 2011, Current opinion in psychiatry.

[26]  P. McGuire,et al.  Can antidepressants prevent psychosis? , 2007, The Lancet.

[27]  M. Berk,et al.  Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder. , 2012, Current pharmaceutical design.

[28]  P. McGuire,et al.  Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. , 2012, Archives of general psychiatry.

[29]  M. Berk,et al.  A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults. , 2010, Journal of affective disorders.

[30]  J. Klosterkötter,et al.  Intervention in at-risk states for developing psychosis , 2010, European Archives of Psychiatry and Clinical Neuroscience.

[31]  L. Abramson,et al.  The early course of depression: a longitudinal investigation of prodromal symptoms and their relation to the symptomatic course of depressive episodes. , 2010, Journal of abnormal psychology.

[32]  P. McGuire,et al.  Cognitive functioning in prodromal psychosis: a meta-analysis. , 2012, Archives of general psychiatry.

[33]  R. Orwin A fail-safe N for effect size in meta-analysis. , 1983 .

[34]  P. McGuire,et al.  Disorganization/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis. , 2012, Schizophrenia bulletin.

[35]  D. Nieman,et al.  Three‐year course of clinical symptomatology in young people at ultra high risk for transition to psychosis , 2011, Acta psychiatrica Scandinavica.

[36]  G. Juckel,et al.  Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. , 2010, Archives of general psychiatry.

[37]  S. Wood,et al.  The psychosis threshold in Ultra High Risk (prodromal) research: Is it valid? , 2010, Schizophrenia Research.

[38]  T. McGlashan,et al.  Recruitment and treatment practices for help-seeking "prodromal" patients. , 2007, Schizophrenia bulletin.

[39]  J. Suvisaari,et al.  Lifetime prevalence of psychotic and bipolar I disorders in a general population. , 2007, Archives of general psychiatry.

[40]  A. Yung,et al.  Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis , 2007, Schizophrenia Research.

[41]  T. McGlashan,et al.  The psychosis high-risk state: a comprehensive state-of-the-art review. , 2013, JAMA psychiatry.

[42]  Joaquim Radua,et al.  Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies. , 2012, Schizophrenia bulletin.

[43]  Philip K. McGuire,et al.  Reductions in frontal, temporal and parietal volume associated with the onset of psychosis , 2008, Schizophrenia Research.

[44]  M. Large,et al.  Rates of homicide during the first episode of psychosis and after treatment: a systematic review and meta-analysis. , 2010, Schizophrenia bulletin.

[45]  Charlton Cheung,et al.  Are Bipolar Disorder and Schizophrenia Neuroanatomically Distinct? An Anatomical Likelihood Meta-analysis , 2010, Front. Hum. Neurosci..

[46]  J. Os,et al.  A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness–persistence–impairment model of psychotic disorder , 2008, Psychological Medicine.

[47]  Christian Gaser,et al.  Neuroanatomical correlates of different vulnerability states for psychosis and their clinical outcomes. , 2009, The British journal of psychiatry : the journal of mental science.

[48]  A. Bechdolf,et al.  Validation of “prodromal” criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up , 2008, Schizophrenia Research.

[49]  Tyrone D. Cannon,et al.  Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. , 2008, Archives of general psychiatry.

[50]  Hok Pan Yuen,et al.  Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features , 2004, Schizophrenia Research.

[51]  Matthew J. Kempton,et al.  Neuroanatomy of vulnerability to psychosis: A voxel-based meta-analysis , 2011, Neuroscience & Biobehavioral Reviews.

[52]  Tyrone D. Cannon,et al.  Markers of Basal Ganglia Dysfunction and Conversion to Psychosis: Neurocognitive Deficits and Dyskinesias in the Prodromal Period , 2010, Biological Psychiatry.

[53]  C. Correll,et al.  Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. , 2007, The Journal of clinical psychiatry.

[54]  J. Klosterkötter,et al.  Diagnosing schizophrenia in the initial prodromal phase , 2000, Schizophrenia Research.

[55]  A. Mackinnon,et al.  Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. , 2010, Archives of general psychiatry.

[56]  Godfrey D Pearlson,et al.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. , 2003, Schizophrenia bulletin.

[57]  Tyrone D. Cannon,et al.  Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. , 2009, Schizophrenia bulletin.

[58]  J. van Os,et al.  Should attenuated psychosis syndrome be a DSM-5 diagnosis? , 2011, The American journal of psychiatry.

[59]  O. Mason,et al.  Risk factors for transition to first episode psychosis among individuals with ‘at-risk mental states’ , 2004, Schizophrenia Research.

[60]  J. Talbott Outreach and Support in South London (OASIS). Outcomes of non-attenders to a service for people at high risk of psychosis: the case for a more assertive approach to assessment , 2012 .

[61]  G. Pell,et al.  Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study. , 2012 .

[62]  S. Bazemore,et al.  Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis. , 2010, Journal of the American Medical Association (JAMA).